Document is current
Any future updates will be listed below
-
Authors
Bailey, Cate https://orcid.org/0000-0001-5030-430X
Howell, Martin https://orcid.org/0000-0001-9740-712X
Raghunandan, Rakhee https://orcid.org/0000-0001-7848-6109
Dalziel, Kim https://orcid.org/0000-0003-4972-8871
Howard, Kirsten https://orcid.org/0000-0002-0918-7540
Mulhern, Brendan https://orcid.org/0000-0003-3656-8063
Petrou, Stavros https://orcid.org/0000-0003-3121-6050
Rowen, Donna https://orcid.org/0000-0003-3018-5109
Salisbury, Amber https://orcid.org/0000-0003-1557-5918
Viney, Rosalie https://orcid.org/0000-0002-0039-9635
Lancsar, Emily https://orcid.org/0000-0003-2404-6735
Devlin, Nancy https://orcid.org/0000-0002-1561-5361
-
Funding
Funding for this research was provided by:
MRFF (1200816)
MRFF (1199902)
University of Sydney
- License Information
-
More Information
Article History
Accepted: 25 October 2023
First Online: 13 January 2024
Declarations
:
: Open Access funding enabled and organized by CAUL and its Member Institutions. Details of funding sources that supported the work; The QUOKKA MRFF1200816 and TORCH APP1199902 research programmes are funded by the Australian Medical Research Future Fund, Preventive and Public Health Research Initiative – 2019, Targeted Health System and Community Organisation Research Grants. SP receives support as a UK National Institute of Health Research (NIHR) Senior Investigator (NF-SI-0616-10103) and from the NIHR Applied Research Collaboration Oxford and Thames Valley.
: Cate Bailey, Martin Howell, Rakhee Raghunandan, Kim Dalziel, Kirsten Howard, Brendan Mulhern, Stavros Petrou, Donna Rowen, Amber Salisbury, Rosalie Viney, Emily Lancsar, and Nancy Devlin have no conflicts of interest to declare in relation to this work. It should be noted that Nancy Devlin, Brendan Mulhern, Rosalie Viney and Donna Rownen are members of the EuroQol Group, Nancy Devlin is Chair of the Board of the EuroQol Research Foundation, and Rosalie Viney is Chair of the Scientific Executive of the EuroQol Group.
: Conceptualization: ND, EL, CB, MH, RR. Methodology: EL, ND, CB, MH, RR. Formal analysis and investigation: CB, MH, RR, AS. Writing—original draft preparation: ND, CB. Writing—review and editing: EL, ND, CB, MH, RR, KD, KH, BM, RV, SP, DR, AS. Funding acquisition: ND, EL.
: All data is presented either within the paper or in the supplementary files.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
